Durham, United Kingdom · Founded 2014 · Privately Held (backing)
Operator of a biopharmaceutical company intended to treat lung disease with excess mucus and mucus plugs. Aer Therapeutics is based in Durham, United Kingdom and was founded in 2014. It was valued at $58 million at a debt round in Mar 2025, the last priced event on record. It has raised $48 million across 2 recorded rounds; the latest was a $5 million early-stage round in Jan 2025.
PMV mark · valuation
$58.0M
Oct 2026
Priced at
a debt round
Mar 2025
Total raised
$48.0M
Last round
Early Stage VC
Jan 2025
Cap table — not yet on record
Aer Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aer Therapeutics with a free account
·Watch Aer Therapeutics: the Monday email on marks, rounds and moves
Where does Aer Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Aer Therapeutics's 2 recorded funding rounds.
Aer Therapeutics Cap Table & Share Classes | Premier Alternatives
